Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,530,743
+$466,763 QoQ
Shares Held
10,057
+6.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#1,771
of 4,153 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Balboa Wealth Partners holds $9,778,849 across 9 Drug Manufacturers - General names. ABBV ranks #1 (25.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
10,057 | $2,530,743 | |
| 2 | JNJ |
Johnson & Johnson
|
9,731 | $2,471,382 | |
| 3 | LLY |
ELI LILLY & Co
|
1,478 | $1,772,757 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,729 | $864,676 | |
| 5 | NVO |
Novo Nordisk A S
|
15,451 | $740,720 | |
| 6 | PFE |
Pfizer Inc
|
26,316 | $633,689 | |
| 7 | AMGN |
Amgen Inc
|
907 | $328,442 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,742 | $220,084 |
All Filings in ABBV
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,530,743 | 10,057 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,063,980 | 9,490 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $2,247,884 | 9,838 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $2,191,063 | 9,463 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,695,638 | 9,135 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,636,351 | 7,810 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,278,196 | 7,193 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,359,649 | 6,885 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,276,108 | 7,440 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,237,915 | 6,798 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,024,506 | 6,611 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,061,754 | 7,123 | Shares | Defined | 2023-10-23 | |
| 2023-06-30 | $919,397 | 6,824 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $1,178,700 | 7,396 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,299,506 | 8,041 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,073,411 | 7,998 | Shares | Sole | 2023-01-04 | |
| No filing history on record for this holder in this stock. | ||||||